Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Jiang

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of General Internal Medicine|December 9, 2025
Abnormal Flagging of Prostate Specific Antigen Screening Tests: A Regression Discontinuity DesignPatrick Lewicki, Ralph Jiang, Archana Radhakrishnan, et al.
Annals of Internal Medicine|January 12, 2026
Predicting Long-Term Risk for Prostate Cancer Mortality Following a Prostate-Specific Antigen Screening Test: Prognostic Model Development and External ValidationPatrick Lewicki, Ralph Jiang, Archana Radhakrishnan, et al.
JCO Oncology Practice|September 11, 2025
How Sticky Are Clinical Trial Interventions? Site-Level Clinical Trial Participation and Differential Post-Trial Use of a Genomic TestPatrick Lewicki, Ralph Jiang, Udit Singhal, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2023
Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung CancerDonna M Edwards, Kamya Sankar, Aaren Alseri, et al.
Cancer Medicine|November 7, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare SystemSean R Miller, Matthew Schipper, Lars G Fritsche, et al.
Cancer Medicine|June 20, 2024
Artificial intelligence to unlock real-world evidence in clinical oncology: A primer on recent advancesAlex K Bryant, Rafael Zamora-Resendiz, Xin Dai, et al.
JAMA Network Open|January 11, 2023
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysisRandy A Vince, Ralph Jiang, Merrick Bank, et al.
The Lancet. Oncology|November 17, 2024
Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort studySean Miller, Ralph Jiang, Matthew Schipper, et al.
JNCI Cancer Spectrum|April 24, 2026
Understanding randomized controlled trial generalizability through an embedded molecular diagnostics trialPatrick Lewicki, Arnav Srivastava, Ralph Jiang, et al.
Cancer|June 10, 2024
Impact of lung cancer screening on stage migration and mortality among the national Veterans Health Administration population with lung cancerDonna M Edwards, Mina Pirzadeh, Tony Van, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of General Internal Medicine|December 9, 2025
Abnormal Flagging of Prostate Specific Antigen Screening Tests: A Regression Discontinuity DesignPatrick Lewicki, Ralph Jiang, Archana Radhakrishnan, et al.
Annals of Internal Medicine|January 12, 2026
Predicting Long-Term Risk for Prostate Cancer Mortality Following a Prostate-Specific Antigen Screening Test: Prognostic Model Development and External ValidationPatrick Lewicki, Ralph Jiang, Archana Radhakrishnan, et al.
JCO Oncology Practice|September 11, 2025
How Sticky Are Clinical Trial Interventions? Site-Level Clinical Trial Participation and Differential Post-Trial Use of a Genomic TestPatrick Lewicki, Ralph Jiang, Udit Singhal, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2023
Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung CancerDonna M Edwards, Kamya Sankar, Aaren Alseri, et al.
Cancer Medicine|November 7, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare SystemSean R Miller, Matthew Schipper, Lars G Fritsche, et al.
Cancer Medicine|June 20, 2024
Artificial intelligence to unlock real-world evidence in clinical oncology: A primer on recent advancesAlex K Bryant, Rafael Zamora-Resendiz, Xin Dai, et al.
JAMA Network Open|January 11, 2023
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysisRandy A Vince, Ralph Jiang, Merrick Bank, et al.
The Lancet. Oncology|November 17, 2024
Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort studySean Miller, Ralph Jiang, Matthew Schipper, et al.
JNCI Cancer Spectrum|April 24, 2026
Understanding randomized controlled trial generalizability through an embedded molecular diagnostics trialPatrick Lewicki, Arnav Srivastava, Ralph Jiang, et al.
Cancer|June 10, 2024
Impact of lung cancer screening on stage migration and mortality among the national Veterans Health Administration population with lung cancerDonna M Edwards, Mina Pirzadeh, Tony Van, et al.
Pageof 2